J. Garweg SWITZERLAND

16:15 Welcome

E. Aydin TURKEY

16:17 The Investigation of Relationship between Diabetes, Diabetic Neuropathy, and Retinal Neurodegeneration

T-E. Tan SINGAPORE

16:22 Retinal Neural Dysfunction in Diabetes Revealed with Handheld Chromatic Pupillometry

P. Schlottmann ARGENTINA

16:27 Efficacy, Durability and Safety of Faricimab in Diabetic Macular Edema: 2-Year Results From the Phase 3 YOSEMITE and RHINE Trials

M. Barakat USA

16:32 Brolucizumab for the Treatment of Diabetic Macular Edema: 52-week Results from the KINGFISHER Study

J. Garweg SWITZERLAND

16:37 Brolucizumab for treatment of diabetic macular edema (DME): 100-week results from the KESTREL and KITE studies

R. Khoramnia GERMANY

16:42 Safety and effectiveness of the fluocinolone acetonide intravitreal implant (ILUVIEN): 3-year results from the European IRISS registry study

J. Garweg SWITZERLAND

16:47 Effect of Finerenone on Occurrence of Vision-threatening Events in Patients with DR

A.M. Martínez SPAIN

16:52 Anatomical biomarkers after dexamethasone intravitreal implant in diabetic macular edema patients according to new ESASO Classification

All Faculty

16:57 Discussion